The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Plant architecture is a complex trait and has a profound impact on crop performance and productivity. We applied the CRISPR/Cas9 system to mutate the DEP1 gene, which has been reported to function as regulator of plant architecture, in elite Xian cultivar ‘Huhan1509’. Sequencing analysis of T0 transformed plants showed that the CRISPR/Cas9 system was highly efficient in mutagenesis of targeted DEP1...
Immunotherapies, such as chimeric antigen receptor (CAR) modified T cells and antibody‐drug conjugates (ADCs), have revolutionized the treatment of cancer, especially of lymphoid malignancies. The application of targeted immunotherapy to patients with acute myeloid leukemia (AML) has been limited in particular by the lack of a tumor‐specific target antigen. Gemtuzumab ozogamicin (GO), an ADC targeting...